Higher rate of recall, lower sensitivity, larger tumor diameter, and more lymph node-positive disease observed in women with dense breasts.
Computer analysis is not better than human clinical evaluation when it comes to measuring breast densityMay 17, 2018
1. Similar associations were observed with clinical BI-RADS and automated BI-RADS with respect to interval and screen-detected cancer. 2. Both automated and clinical BI-RADS showed similar discriminatory accuracy and mammography accuracy. Evidence Rating Level: 2 (Good) Study Rundown: In the United States, the standard for monitoring breast density is through the Breast Imaging Reporting and 
A study using a cohort of women from Kaiser Permanente Washington evaluated the accuracy of risk assessment models for breast cancer that included classic risk factors with and without breast density as an additional factor during more than 10 years of follow-up.
[Cancer Control] This research reviews the evidence regarding breast density as a risk factor for the development of breast cancer and presents a management strategy for screening women with dense breasts.
Supplementation with vitamin D3 in premenopausal women does not have a significant effect on breast density percentage, nor does it reduce breast cancer risk.
High mammographic breast density is a risk factor for primary breast cancer. In this study, a potential correlation with contralateral breast cancer was investigated.
Discovered link between inflammation and overexpression of CCL2 hints at potential of anti-inflammatory medications as a breast cancer preventive in women with dense-tissue breasts.
Features mainly linked to mammographic breast density are key in influencing a classification of normal.
History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer DiagnosisDecember 09, 2016
A history of surgical menopause and were receiving hormone replacement therapy are a factor in breast density, according to a study presented at the 2016 San Antonio Breast Cancer Symposium (SABCS).
Study data indicate that women who ate a Western diet also had 46 percent higher risk of breast cancer.
The definition of dense breasts can range from 6.3 to 84.5 percent of patients, depending on radiologist.
Both automated and clinical assessments of breast density are associated with breast cancer risk.
Diabetes treatments, such as diet or pills (eg, metformin), decrease mammographic density, whereas insulin may increase mammographic density.
Breast density assessments can vary for as many as 19% of women, which can lead to inconsistent information regarding the need for additional clinical screenings.
Not all women with dense breasts have a high enough breast cancer risk to justify additional imaging after a normal mammogram, according to a recent study.
Five-year risk plus breast density can best identify women at high risk for interval cancer.
Lowest variability seen in Volpara and Quantra; higher variability for Cumulus ABD and CumulusV methods.
A low degree of mammographic breast density worsens the prognosis of breast cancer, according to a recent study.
Disparities exist regarding the level of awareness and knowledge of breast density among US women, according to a study.
Half of primary care physicians are still unfamiliar with the California law mandating that clinicians notify women with dense breast tissue, and many do not feel comfortable answering breast density-related questions.
Semiautomated computer-derived measurements are consistent with radiologist assessments, according to a study.
Automated breast density measurement is predictive of breast cancer risk in younger women, and that risk may be related to the rate at which breast density changes in some women as they age, according to research.
Mammographic density is associated with breast cancer among women younger than 50 years, according to a study.
A website has been developed to help navigate the new challenges posed by breast-density notification laws, according to a recent special report.
HRT-linked risk up for white, Asian, Hispanic women; for low/normal BMI and dense breasts.
For women treated with tamoxifen, decrease in mammographic density tied to improved survival.
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Endocrine Society Released Guidelines for Managing Endocrine Disorders in Childhood Cancer Survivors
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|